Novartis Aktie
98,72
EUR
-0,68
EUR
-0,68
%
91,55
CHF
-0,74
CHF
-0,80
%
Werbung
Novartis Aktie Analyse
28.03.23 | Novartis Hold | Deutsche Bank AG | |
27.03.23 | Novartis Buy | Jefferies & Company Inc. | |
14.03.23 | Novartis Sell | Deutsche Bank AG | |
17.02.23 | Novartis Sell | Deutsche Bank AG | |
13.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
07.02.23 | Novartis Sell | Deutsche Bank AG | |
06.02.23 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
03.02.23 | Novartis Neutral | JP Morgan Chase & Co. | |
Werbung
|
|||
02.02.23 | Novartis Underperform | Credit Suisse Group | |
02.02.23 | Novartis Sell | Deutsche Bank AG | |
01.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
01.02.23 | Novartis Buy | Jefferies & Company Inc. | |
01.02.23 | Novartis Neutral | UBS AG | |
25.01.23 | Novartis Underweight | Barclays Capital | |
24.01.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
09.01.23 | Novartis Neutral | UBS AG | |
06.01.23 | Novartis Underperform | Credit Suisse Group | |
06.01.23 | Novartis Underweight | Morgan Stanley | |
05.01.23 | Novartis Buy | Jefferies & Company Inc. | |
03.01.23 | Novartis Neutral | JP Morgan Chase & Co. | |
23.12.22 | Novartis Underweight | Barclays Capital | |
14.12.22 | Novartis Neutral | UBS AG | |
12.12.22 | Novartis Buy | Jefferies & Company Inc. | |
09.12.22 | Novartis Sell | Deutsche Bank AG | |
08.12.22 | Novartis Market-Perform | Bernstein Research | |
08.12.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
07.12.22 | Novartis Sell | Deutsche Bank AG | |
06.12.22 | Novartis Neutral | UBS AG | |
22.11.22 | Novartis Sell | Deutsche Bank AG | |
27.10.22 | Novartis Sell | Deutsche Bank AG | |
26.10.22 | Novartis Market-Perform | Bernstein Research | |
26.10.22 | Novartis Underperform | Credit Suisse Group | |
26.10.22 | Novartis Underweight | JP Morgan Chase & Co. | |
26.10.22 | Novartis Underweight | Barclays Capital | |
25.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
25.10.22 | Novartis Sell | Deutsche Bank AG | |
25.10.22 | Novartis Neutral | UBS AG | |
25.10.22 | Novartis Buy | Jefferies & Company Inc. | |
24.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.22 | Novartis Underweight | Barclays Capital | |
07.10.22 | Novartis Sell | Deutsche Bank AG | |
05.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
26.09.22 | Novartis Neutral | UBS AG | |
23.09.22 | Novartis Sell | Deutsche Bank AG | |
23.09.22 | Novartis Underweight | Barclays Capital | |
23.09.22 | Novartis Underperform | Credit Suisse Group | |
23.09.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
21.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
21.09.22 | Novartis Sell | Deutsche Bank AG | |
16.09.22 | Novartis Underweight | JP Morgan Chase & Co. |
Werbung
Werbung